An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)
Clinical trial NCT06690489 · COMPLETED
Trial details
- NCT number
- NCT06690489
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-22
- Primary completion
- 2025-11-26
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.